EVIDENCE LIBRARY
Bronchoscopy Stimulation Trial: Less Cough Did Not Mean Less Midazolam
A randomized bronchoscopy study reported lower cough scores with electrical acupoint stimulation but no significant reduction in midazolam dosage.
A randomized bronchoscopy study reported lower cough scores with electrical acupoint stimulation but no significant reduction in midazolam dosage.
Different endpoints moved differently
One hundred patients were allocated to stimulation before bronchoscopy or a control procedure without stimulation. Cough scores and lidocaine and fentanyl requirements favored stimulation. Midazolam dosage, discomfort scores, sedation level, oxygen-related measures, and several other outcomes did not differ significantly between groups.
What the findings support
The results support a limited statement about cough and selected medication requirements in this setting. They do not support calling the intervention benzodiazepine-sparing or claiming that it improved all aspects of sedation. The single-center sample was modest, no nonacupoint stimulation arm was included, and the study did not establish that effects were specific to the selected points. A biomarker difference also does not by itself prove the proposed mechanism. For procedural review, describe cough control, patient experience, sedation exposure, and respiratory events separately.
Source paper
Original analysis of the supplied journal article, identified as PMC6885814.